导航诊断困境:一个病例系列诊断困境在中枢神经系统(CNS)感染解决分子测序

Sreethish Sasi , Fatma Ben Abid , Maisa Ali , Junais Koleri , Jabeed Parengal , Waleed Awouda , Manal Hamed , Faiha Eltayeb , Andrez Perez-Lopez , Muna Al-Maslamani , Abdullatif Al-Khal , Mohamed Abukhattab
{"title":"导航诊断困境:一个病例系列诊断困境在中枢神经系统(CNS)感染解决分子测序","authors":"Sreethish Sasi ,&nbsp;Fatma Ben Abid ,&nbsp;Maisa Ali ,&nbsp;Junais Koleri ,&nbsp;Jabeed Parengal ,&nbsp;Waleed Awouda ,&nbsp;Manal Hamed ,&nbsp;Faiha Eltayeb ,&nbsp;Andrez Perez-Lopez ,&nbsp;Muna Al-Maslamani ,&nbsp;Abdullatif Al-Khal ,&nbsp;Mohamed Abukhattab","doi":"10.1016/j.hmedic.2025.100202","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.</div></div><div><h3>Case presentations</h3><div>We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.</div></div><div><h3>Discussion</h3><div>Pathogens identified through sequencing included <em>Klebsiella pneumoniae</em>, <em>Moraxella osloensis</em>, <em>Streptococcus intermedius</em>, <em>Candida albicans</em>, <em>Streptococcus pneumoniae</em>, <em>Brucella melitensis</em>, and <em>Brucella abortus</em>. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.</div></div><div><h3>Conclusion</h3><div>Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.</div></div>","PeriodicalId":100908,"journal":{"name":"Medical Reports","volume":"11 ","pages":"Article 100202"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Navigating diagnostic quandaries: A case series of diagnostic dilemmas in central nervous system (CNS) infections resolved by molecular sequencing\",\"authors\":\"Sreethish Sasi ,&nbsp;Fatma Ben Abid ,&nbsp;Maisa Ali ,&nbsp;Junais Koleri ,&nbsp;Jabeed Parengal ,&nbsp;Waleed Awouda ,&nbsp;Manal Hamed ,&nbsp;Faiha Eltayeb ,&nbsp;Andrez Perez-Lopez ,&nbsp;Muna Al-Maslamani ,&nbsp;Abdullatif Al-Khal ,&nbsp;Mohamed Abukhattab\",\"doi\":\"10.1016/j.hmedic.2025.100202\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.</div></div><div><h3>Case presentations</h3><div>We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.</div></div><div><h3>Discussion</h3><div>Pathogens identified through sequencing included <em>Klebsiella pneumoniae</em>, <em>Moraxella osloensis</em>, <em>Streptococcus intermedius</em>, <em>Candida albicans</em>, <em>Streptococcus pneumoniae</em>, <em>Brucella melitensis</em>, and <em>Brucella abortus</em>. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.</div></div><div><h3>Conclusion</h3><div>Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.</div></div>\",\"PeriodicalId\":100908,\"journal\":{\"name\":\"Medical Reports\",\"volume\":\"11 \",\"pages\":\"Article 100202\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949918625000476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949918625000476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景中枢神经系统(CNS)感染的病因多种多样,而且传统诊断方法存在局限性,因此给诊断带来了巨大挑战。标准的脑脊液(CSF)培养和聚合酶链反应(PCR)检测往往无法确定致病病原体,尤其是在曾接受过抗菌治疗的患者中。16S 和 18S 核糖体 RNA(rRNA)测序技术的出现彻底改变了微生物鉴定方法,它能以极高的灵敏度和特异性检测出多种细菌和真菌病原体。讨论通过测序确定的病原体包括肺炎克雷伯菌、奥斯陆摩拉菌、中间链球菌、白色念珠菌、肺炎链球菌、梅毒布鲁氏菌和流产布鲁氏菌。在所有病例中,测序都能实现有针对性的抗菌治疗,从而取得良好的临床效果。在标准诊断失败的部分细菌性脑膜炎、真菌性中枢神经系统感染和神经布鲁氏菌病病例中,这种方法被证明特别有用。分子测序技术的应用可提高病原体检测能力,指导适当的抗菌治疗,并改善临床疗效。随着测序技术的普及,将其纳入常规诊断工作流程可能会重新定义中枢神经系统感染的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Navigating diagnostic quandaries: A case series of diagnostic dilemmas in central nervous system (CNS) infections resolved by molecular sequencing

Background

Central nervous system (CNS) infections present a significant diagnostic challenge due to their diverse etiologies and the limitations of conventional diagnostic methods. Standard cerebrospinal fluid (CSF) culture and polymerase chain reaction (PCR) assays often fail to identify causative pathogens, particularly in patients who have received prior antimicrobial therapy. The advent of 16S and 18S ribosomal RNA (rRNA) sequencing has revolutionized microbial identification by enabling the detection of a wide range of bacterial and fungal pathogens with high sensitivity and specificity.

Case presentations

We present a retrospective case series of six patients with CNS infections that remained undiagnosed using conventional microbiological methods but were successfully identified using molecular sequencing. Clinical presentations, CSF findings, imaging studies, and treatment outcomes were analyzed to assess the impact of 16S/18S rRNA sequencing on diagnosis and patient management.

Discussion

Pathogens identified through sequencing included Klebsiella pneumoniae, Moraxella osloensis, Streptococcus intermedius, Candida albicans, Streptococcus pneumoniae, Brucella melitensis, and Brucella abortus. In all cases, sequencing enabled targeted antimicrobial therapy, leading to favorable clinical outcomes. This method proved particularly useful in cases of partially treated bacterial meningitis, fungal CNS infections, and neurobrucellosis, where standard diagnostics failed.

Conclusion

Molecular sequencing serves as a powerful diagnostic tool for CNS infections, especially in culture-negative cases. Its implementation enhances pathogen detection, guides appropriate antimicrobial therapy, and improves clinical outcomes. As sequencing technology becomes more accessible, its integration into routine diagnostic workflows may redefine the approach to CNS infection management.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信